Literature DB >> 16979430

Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer.

Ignace Vergote, Frederic Amant.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16979430     DOI： 10.1016/j.ygyno.2006.08.001

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  2 in total

1.  Optimal treatment of early-stage ovarian cancer.

Authors:  F Collinson; W Qian; R Fossati; A Lissoni; C Williams; M Parmar; J Ledermann; N Colombo; A Swart
Journal:  Ann Oncol       Date:  2014-03-14       Impact factor: 32.976

2.  Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers.

Authors:  Birgitte Nielsen; Andreas Kleppe; Tarjei Sveinsgjerd Hveem; Manohar Pradhan; Rolf Anders Syvertsen; John Arne Nesheim; Gunnar Balle Kristensen; Jone Trovik; David James Kerr; Fritz Albregtsen; Håvard Emil Danielsen
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.